More on CELG
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net income | 1.57B |
| Depreciation of long-term assets | 89.6M |
| Amortization | |
| Allocation of pre-paid royalties | |
| Provision (benefit) for accounts receivable allowances | |
| Deferred income taxes | -256.8M |
| Impairment of acquired in-process research and development | 187.1M |
| Change in value of contingent consideration | |
| Share-based compensation expense | 451.7M |
| Equity in (gains) losses of affiliated companies | |
| Share-based employee benefit plan expense | 28.7M |
| Unrealized change in value of foreign currency forward contracts | |
| Realized (gain) loss on marketable securities available for sale | |
| Other, net | -9.3M |
| Accounts receivable | -143.8M |
| Inventory | -62.3M |
| Other operating assets | 137.2M |
| Assets held for sale, net | |
| Accounts payable and other operating liabilities | 163.9M |
| Income tax payable | 27.9M |
| Deferred revenue | 11.6M |
| Net cash provided by operating activities | 2.63B |
| Proceeds from sales of marketable securities available for sale | |
| Purchases of marketable securities available for sale | |
| Payments for acquisition of business, net of cash acquired | 0 |
| Proceeds from the sale of non-core assets, net | |
| Capital expenditures | -169.8M |
| Investment in affiliated companies | |
| Purchases of investment securities | |
| Net cash provided by (used in) investing activities | -298M |
| Payment for treasury shares | -2.03B |
| Net proceeds from exercise of common stock options and warrants | 190.8M |
| Excess tax benefit from share-based compensation arrangements | 129.8M |
| Net cash provided by (used in) financing activities | -1.7B |
| Effect of currency rate changes on cash and cash equivalents | |
| Net increase (decrease) in cash and cash equivalents | 642.3M |
| Cash and cash equivalents at beginning of period | 4.88B |
| Cash and cash equivalents at end of period | 5.52B |
| Contingent consideration issued in acquisition of Gloucester | |
| Change in net unrealized (gain) loss on marketable securities available for sale | 361M |
| Matured shares tendered in connection with stock option exercises | |
| Interest paid | 463.3M |
| Income taxes paid | 345.1M |
Entities mentioned with CELG
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- JPMorgan | View Related Stories »
- Citi | View Related Stories »
- Jefferies & Co | View Related Stories »
- Morgan Stanley | View Related Stories »
- Show More...
